AWC
IGC icon

Abundance Wealth Counselors’s IGC Pharma IGC Stock Holding History

Abundance Wealth Counselors’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-400
Closed -$1K – 207
2021
Q1 		$1K Buy
+400
New +$727 ﹤0.01% 346

Other funds holding IGC

IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Abundance Wealth Counselors's IGC Position: Q2 2021 in Review

Abundance Wealth Counselors sold out of IGC Pharma (IGC) in Q2 2021, closing a stake of 400 shares — an estimated $1K sold.

Abundance Wealth Counselors first reported a position in IGC in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 29 funds tracked by Wall St. Rank hold IGC as of Q2 2021.

  • Abundance Wealth Counselors reported no remaining IGC Pharma position as of Q2 2021 after selling out during the quarter.
  • Abundance Wealth Counselors sold 400 IGC Pharma shares in Q2 2021, an estimated $1K.
  • Abundance Wealth Counselors first reported a position in IGC Pharma in Q1 2021 and held it in 1 quarter.
  • Abundance Wealth Counselors's IGC Pharma position peaked at $1K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2021.

Based on Abundance Wealth Counselors's 13F filing for Q2 2021, filed 21 Jul 2021.